Simpirica Spine has secured $22 million in a series C round of venture capital financing. The investment round was led by new investor Norwest Venture Partners (NVP). Existing investors De Novo Ventures and U.S. Venture Partners also took part in the fundraising process, which will be used to support the European commercialization of the company’s lead product. Simpirica Spine was founded in 2006 to develop minimally invasive, flexion-restricting stabilization devices for the spine.
Click here for the release from Business Wire.